NCT06640647View on ClinicalTrials.gov

Phase Ia Clinical Study of HDM1005 Injection

PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 19, 2024

Primary Completion Date

August 6, 2024

Study Completion Date

September 26, 2024

Conditions
Obesity and Overweight
Interventions
DRUG

HDM1005 injection or placebo

HDM1005 injection or placebo isubcutaneous injection once

Trial Locations (1)

Unknown

The Second Affiliated Hospital of Anhui Medical University, Hefei

All Listed Sponsors
lead

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

INDUSTRY

NCT06640647 - Phase Ia Clinical Study of HDM1005 Injection | Biotech Hunter | Biotech Hunter